• Home
• News
• About Us
• Contact

Search

Tag Cloud

anthrax Strategic National Stockpile Training exercise Bioterror Biomagnetics National Research Council Homeland Security Biodefense lab Army Medical Research Institute antibiotics Emergency preparedness research Bioweapons NIAID smallpox Detection technology CDC TSA Defense Dept IAEM FEMA immunization Ebola Ricin Hendra Plague treaty West Nile Camouflage Paint Marburg antidote weapons destruction Sarin VHF viruses chemical disposal dna technology prevention Robotics Technology research grants tularemia weapons control foot and mouth disease decontamination E. coli Iraq missile defense Bio-Rescue Dengue fever Botulinum toxin antiviral molecular diagnostics Infectious disease

Subscribe to our newsletter

RSS Feed

JPL develops high-speed test to improve pathogen decontamination
by Pat Dulnier on October 26, 2009

A chemist at NASA's Jet Propulsion Laboratory in Pasadena, Calif., has developed a technology intended to rapidly assess any presence of microbial life on spacecraft.

FDA to discuss experimental drug’s effectiveness against anthrax
by Mary J. Lewis on October 26, 2009

A Human Genome Sciences Inc. drug worked better than a placebo but similar to antibiotics for treating anthrax exposure in animal studies, U.S. drug reviewers said in a summary released Oct. 23.

New York prepares response to anthrax attack
by Paul Tinder on September 14, 2009

NEW YORK – The City’s Department of Health tested its readiness to respond to an anthrax attack with an antibiotics and vaccine distribution drill this week at a Lower East Side school.

Emergent BioSolutions submits development plan for anthrax vaccine
by Ted Purlain on September 14, 2009

ROCKVILLE, Md -- Emergent BioSolutions Inc. has submitted a development plan to the FDA for its Recombinant Protective Antigen (rPA) anthrax vaccine candidate.

Panel evaluates implementation of Project BioShield, procurement of vaccines
by Daniel Purt on December 8, 2008

WASHINGTON, D.C. — At the National Press Club on Dec. 8, 2005, a panel of three internationally known biodefense and vaccine experts discussed the implementation of Project BioShield, the procurement process for biodefense vaccines.